Blog

Top 25 AI Companies Close to Clinical Impact in 2024

A list of the top AI companies close to clinical impact in 2025.

deepmirror secures $2.4M to help chemists design drugs with one click

While AI could help chemists design optimal drug molecules faster, implementing it remained out of reach for most companies. deepmirror has raised $2.4M to simplify the adoption of AI for molecule design, enabling companies to get drugs to patients faster with their accessible AI-powered platform.

What’s going on with AI in Drug Discovery?

Artificial intelligence is all over the headlines and promises to revolutionize drug development. There are claims that AI is “taking...

Bridging Skepticism and Innovation: How AI Empowers Chemists in Drug Discovery

When introduced to the latest AI tool promising to revolutionise drug discovery, some seasoned chemists can’t help but feel a familiar...

deepmirror Engine put to the test in the Therapeutics Data Commons benchmark

Accurate prediction of molecular properties such as ADMET is key in designing better molecules. The AI Engine powering DeepMirror (...

One molecular generator to rule them all?

Comparing different molecular generators from LLMs to REINVENT

deepmirror has been awarded an Innovate UK grant

deepmirror has successfully secured an Innovate UK Flexible, Agile, Sustainable, Scalable Technologies (FASS) grant.

deepmirror Obtains ISO27001 Certification

In drug discovery, where intellectual property and confidential data are paramount, ensuring robust security measures is a top priority...

6x faster discovery with deepmirror

How a European biotech used deepmirror to find novel scaffolds for first-in-class oncology drug candidates in just 2 weeks.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.